Table 2.
RFE ranking and selected features from the dataset based on each base model (scenario 3).
| NO | Parameter | RFE ranking (LGB) | Selected features (LGB) | RFE ranking (XGB) | Selected features (XGB) |
|---|---|---|---|---|---|
| 1 | Sex | 39 | 39 | ||
| 2 | Age | 25 | 23 | ||
| 3 | Height | 26 | 34 | ||
| 4 | Weight | 28 | 30 | ||
| 5 | BMI | 4 | ✓ | 38 | |
| 6 | SBP | 24 | 35 | ||
| 7 | DBP | 34 | 16 | ||
| 8 | PBP | 33 | 31 | ||
| 9 | HR | 13 | 8 | ✓ | |
| 10 | Cr | 15 | 17 | ||
| 11 | Killip class | 30 | 7 | ✓ | |
| 12 | EF LV | 14 | 14 | ||
| 13 | EDV | 27 | 15 | ||
| 14 | ESV | 20 | 13 | ||
| 15 | LVRWTI | 1 | ✓ | 25 | |
| 16 | LVRMI | 2 | ✓ | 11 | |
| 17 | SPAP | 8 | 6 | ✓ | |
| 18 | La1 | 22 | 10 | ||
| 19 | La2 | 31 | 19 | ||
| 20 | Ra1 | 32 | 24 | ||
| 21 | Ra2 | 11 | 12 | ||
| 22 | WBC | 9 | 20 | ||
| 23 | NEUT | 6 | ✓ | 1 | ✓ |
| 24 | LYM | 17 | 26 | ||
| 25 | EOS | 23 | 5 | ✓ | |
| 26 | RBC | 18 | 22 | ||
| 27 | Hb | 10 | 21 | ||
| 28 | PLT | 16 | 36 | ||
| 29 | Glu | 3 | ✓ | 9 | |
| 30 | Urea | 7 | 4 | ✓ | |
| 31 | PCT | 29 | 29 | ||
| 32 | PI | 19 | 32 | ||
| 33 | INR | 12 | 2 | ✓ | |
| 34 | TT | 5 | ✓ | 3 | ✓ |
| 35 | APTT | 21 | 37 | ||
| 36 | Form STEMI | 37 | 28 | ||
| 37 | AFib | 35 | 27 | ||
| 38 | Diabetes | 38 | 33 | ||
| 39 | CKD | 36 | 40 | ||
| 40 | aMI | 40 | 41 | ||
| 41 | COPD | 41 | 18 |